Based on the expression level of TRIM37 in different T-ALL cell lines, Jurkat and RPMI8402 cell lines were selected for knockdown studies and MOLT-4 cell line was selected for overexpression studies. This evidence concerns the gene TRIM37 and acute lymphoblastic leukemia.